Naltrexone Is Safe and Beneficial in AUD With Cirrhosis
Alcohol abstinence was achieved by nearly two thirds of patients with alcohol use disorder (AUD) and cirrhosis after taking naltrexone, with minimal adverse events.
Source: medscape.com
Page 18 - Biliary Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biliary Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biliary Sciences Today - Breaking & Trending Today
Naltrexone achieves abstinence, reduces lapses in patients with alcohol use disorder
Naltrexone was effective in achieving abstinence, reducing lapses and improving craving scores at 3 months in patients with alcohol-related cirrhosis, according to data presented at EASL Congress. “In the largest randomized controlled trial available to date, which is a combined trial with 1,380 patients with alcohol use disorder, naltrexone has been shown to have an increased incidence of
Source: healio.com
Non-Alcoholic Fatty Liver Disease: How India Is Empowering Medical Officers To Tackle NAFLD Burden
Capacity building necessary for medical officers to address the challenges posed by Non-Alcoholic Fatty Liver Diseases (NAFLD) effectively, says Union Health Secretary Rajesh Bhushan. TheHealthSite.com
Source: thehealthsite.com
Poisoned Punjab: A single street in this city is home to some 20 cancer patients
The health impact of polluted Buddha nullah waters affecting Abohar city, finds ground report
Source: downtoearth.org.in
'Moderate liquor consumption can't defy insurance claims'
The Gurugram district consumer grievances redressal forum in a recently passed order has said that moderate consumption of alcohol cannot be used as grounds to reject medical insurance claims.The Forum directed New India Assurance Company ...
Source: prokerala.com